Statistics

Total Visits

Views
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. 185

Total Visits per Month

March 2015 April 2015 May 2015 June 2015 July 2015 August 2015 September 2015
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. 1 0 5 1 0 4 0

File Downloads

Views
ijo_34_4_1155_PDF published.pdf 57

Top Country Views

Views
United States 42
Germany 21
Sweden 19
Canada 18
China 17
France 11
United Kingdom 9
South Korea 5
Russia 5
India 2

Top City Views

Views
Miami Beach 17
Nynäs 16
Toronto 13
Beijing 7
Kansas City 5
Zhengzhou 5
Seoul 3
Ottawa 2
Bangalore 1
Cambridge 1